Project Leader Clinical Development
CurrentResponsible for the design and execution of the clinical development of Byondis' biopharmaceuticals.
Please complete the CAPTCHA to continue
@byondis.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Glenn Van Wigcheren is listed as Project Leader Clinical Development at Byondis, a with 254 employees, based in Nijmegen, Gelderland, Netherlands. AeroLeads shows a work email signal at byondis.com and a matched LinkedIn profile for Glenn Van Wigcheren.
Glenn Van Wigcheren previously worked as Clinical Project Manager at Julius Clinical and PhD student at Radboudumc. Glenn Van Wigcheren holds Doctor Of Philosophy (Phd), Medical Sciences from Radboud University.
This section adds company-level context without repeating Glenn Van Wigcheren's masked contact details.
AeroLeads found 1 current-domain work email signal for Glenn Van Wigcheren. Compare company email patterns before reaching out.
Glenn Van Wigcheren is a Project Leader Clinical Development at Byondis. He possess expertise in immunology, cell biology, tumor immunology, molecular biology, targeted therapies. He is proficient in Fries and English.
Listed skills include Immunology, Cell Biology, Tumor Immunology, Molecular Biology, and 1 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Nijmegen, Gelderland, Nederland
Responsible for the design and execution of the clinical development of Byondis' biopharmaceuticals.
Zeist, Utrecht, Nederland
Responsible for project management in global randomized controlled clinical trials.
Nijmegen En Omgeving, Nederland
Department of Tumor ImmunologyTranslational research in clinical oncology and autoimmunity focusing on targeting or exploiting innate immune cells in future immunotherapies. Of particular interest was the induction and function of myeloid suppressor cells. These include monocytic myeloid-derived suppressor cells, tolerogenic monocyte-derived dendritic cells and CD14+ conventional type 2 dendritic cells.
Amsterdam En Omgeving, Nederland
Department of Pathology, Department of Hematology, LYMMCAREResearch on targeted therapy of the B cell receptor pathway and STAT3 signaling pathway to potentially treat several lymphomas (incl NHL, CLL) and multiple myeloma.
Utrecht En Omgeving, Nederland
Department of Medical MicrobiologyResearch to two leukotoxins of common human and animal pathogen Staphylococcus aureus. A part of the internship was dedicated to revealing the molecular targets and characteristics of LukPQ, a newly discovered leukotoxin in equine S. aureus strains. Thereafter the biological activity of a second recently described leukotoxin LukM/F’ harboured by bovine S. aureus strains was further characterized. LukM/F' is associated with severe mastitis in cows and this project supported an anti-LukM/F' vaccination trial conducted in cows.
Nijmegen En Omgeving, Nederland
Laboratory of Medical ImmunologyResearch to the immunoregulation by regulatory B cells (Bregs) with the aim to support the development of Breg-based immunotherapy.
Other employees you can reach at byondis.com. View company contacts for 254 employees →
Lilian Driessen
Colleague at ByondisNijmegen, Gelderland, Netherlands
View →
CV
Criss Van De Wouw
Colleague at ByondisNijmegen, Gelderland, Netherlands
View →
MW
Menno Winkel
Colleague at ByondisNijmegen, Gelderland, Netherlands
View →
MB
Marijn Buurman
Colleague at ByondisNijmegen, Gelderland, Netherlands
View →
AK
Amina Kolic
Colleague at ByondisNijmegen, Gelderland, Netherlands
View →
SH
Saskia Hoogstraten
Colleague at ByondisArnhem-Nijmegen Region, Netherlands
View →
DD
Désirée Damming
Colleague at ByondisNijmegen, Gelderland, Netherlands
View →
SV
Sanne Van Wyk
Colleague at ByondisDruten, Gelderland, Netherlands
View →
AB
Arne Beukema
Colleague at ByondisBennekom, Gelderland, Netherlands
View →
JG
Jos Golsteijn
Colleague at ByondisEindhoven, North Brabant, Netherlands
View →
Thesis: "Immunomodulation by myeloid cells: Implications for immunotherapy of cancer and autoimmunity"
Elective courses: Vaccines Experimental Oncology (Div. of Immunology, NKI-AvL) Basics of Biostatistics Writing assignment: Literature.
Activities and Societies: N.S.V. Ovum Novum; Medische Faculteits Vereniging Nijmegen
Quick answers generated from the profile data available on this page.
Glenn Van Wigcheren works for Byondis.
Glenn Van Wigcheren is listed as Project Leader Clinical Development at Byondis.
AeroLeads has found 1 work email signal at @byondis.com for Glenn Van Wigcheren at Byondis.
Glenn Van Wigcheren is based in Nijmegen, Gelderland, Netherlands while working with Byondis.
Glenn Van Wigcheren has worked for Byondis, Julius Clinical, Radboudumc, Amc - Academisch Medisch Centrum, and Umc Utrecht.
Glenn Van Wigcheren's colleagues at Byondis include Lilian Driessen, Criss Van De Wouw, Menno Winkel, Marijn Buurman, and Amina Kolic.
You can use AeroLeads to view verified contact signals for Glenn Van Wigcheren at Byondis, including work email, phone, and LinkedIn data when available.
Glenn Van Wigcheren holds Doctor Of Philosophy (Phd), Medical Sciences from Radboud University.
Glenn Van Wigcheren is listed with skills including Immunology, Cell Biology, Tumor Immunology, Molecular Biology, and Targeted Therapies.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts